Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)BOUKOVINAS, Ioannis; ANDROULAKIS, Nikolaos; KOSTAKOPOULOS, Athanasios et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 351-356, issn 0344-5704, 6 p.Article

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancerKOTSAKIS, Athanasios; AGELAKI, Sophia; GEORGOULIAS, Vassilis et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 415-422, issn 0344-5704, 8 p.Article

A Retrospective Analysis of Non-platinum-based First- and Second-line Chemotherapy in Patients with Advanced Non-small Cell Lung CancerKOTSAKIS, Athanasios; HATZIDAKI, Dora; AGELAKI, Sophia et al.Anticancer research. 2010, Vol 30, Num 10, pp 4335-4342, issn 0250-7005, 8 p.Article

Phase III Study Comparing Sequential Versus Alternate Administration of Cisplatin-Etoposide and Topotecan as First-line Treatment in Small Cell Lung CancerBAKA, Sophia; AGELAKI, Sophia; ANDROULAKIS, Nikolaos et al.Anticancer research. 2010, Vol 30, Num 7, pp 3031-3038, issn 0250-7005, 8 p.Article

Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer : A Phase II StudyKOUROUSSIS, Charalambos; VAMVAKAS, Lambros; VARDAKIS, Nikolaos et al.Oncology. 2009, Vol 76, Num 2, pp 112-117, issn 0030-2414, 6 p.Article

A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancerPALLIS, Athanasios G; AGELIDOU, Athina; KENTEPOZIDIS, Nikolaos et al.Lung cancer. 2006, Vol 52, Num 2, pp 165-171, issn 0169-5002, 7 p.Article

A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancerIGNATIADIS, Michail; POLYZOS, Aris; STATHOPOULOS, George P et al.Oncology. 2006, Vol 71, Num 3-4, pp 159-163, issn 0030-2414, 5 p.Article

A phase II trial evaluating the clinical and immunologic response of HLA-A2⁺ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptideKOTSAKIS, Athanasios; PAPADIMITRAKI, Elisavet; KYRIAKI VETSIKA, Eleni et al.Lung cancer. 2014, Vol 86, Num 1, pp 59-66, issn 0169-5002, 8 p.Article

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer : A randomized, multicenter phase III trialGEORGOULIAS, Vassilis; ANDROULAKIS, Nikolaos; CHANDRINOS, Vassilis et al.Lung cancer. 2008, Vol 59, Num 1, pp 57-63, issn 0169-5002, 7 p.Article

A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumorsSARIDAKI, Zacharenia; BOZIONELOU, Vasiliki; MAVROUDIS, Dimitris et al.Oncology. 2007, Vol 72, Num 1-2, pp 45-50, issn 0030-2414, 6 p.Article

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer : a multicentre phase II studyARDAVANIS, Alexandros; MAVROUDIS, Dimitris; GEORGOULIAS, Vassilis et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 6, pp 742-748, issn 0344-5704, 7 p.Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001VETSIKA, Eleni-Kyriaki; KONSOLAKIS, Georgios; AGGOURAKI, Despoina et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 2, pp 157-168, issn 0340-7004, 12 p.Article

Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung CancerTARHINI, Ahmad; KOTSAKIS, Athanasios; GOODING, William et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5900-5907, issn 1078-0432, 8 p.Article

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevanceAPOSTOLAKI, Stella; PERRAKI, Maria; AGELAKI, Sofia et al.Breast cancer research and treatment. 2009, Vol 117, Num 3, pp 525-534, issn 0167-6806, 10 p.Article

Sequential Administration of the Native TERT₅₇₂ Cryptic Peptide Enhances the Immune Response Initiated by its Optimized Variant TERT_572Y in Cancer PatientsVETSIKA, Eleni-Kyriaki; PAPADIMITRAKI, Elisavet; CHRISTOPHYLLAKIS, Charalampos et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 9, pp 641-650, issn 1524-9557, 10 p.Article

A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumorsSARIDAKI, Zacharenia; PAPPAS, Periklis; SOUGLAKOS, John et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 121-128, issn 0344-5704, 8 p.Article

Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer : A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)KALYKAU, Antonia; PAPAKOTOULAS, Pavlos; MAVROUDIS, Dimitris et al.Anticancer research. 2008, Vol 28, Num 1B, pp 495-500, issn 0250-7005, 6 p.Article

Docetaxel-induced lymphopenia in patients with solid tumors : A prospective phenotypic analysisKOTSAKIS, Athanasios; SARRA, Evanthia; PERAKI, Maria et al.Cancer. 2000, Vol 89, Num 6, pp 1380-1386, issn 0008-543XArticle